Efficacy of virtual reality assisted breathing therapy for pain and anxiety relief in patients with cancer receiving systemic chemotherapy

Advancement of Breath-Guided Virtual Reality for Pain and Anxiety Relief in Cancer Patients Undergoing Systemic Chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009588

Enrollment

Registered

2024-07-04

Start date

2024-07-01

Completion date

Unknown

Last updated

2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This study will be conducted in Gangneung Asan Hospital, a tertiary hospital in Gangneung, South Korea. We will recruit 88 patients with advanced or metastatic cancer who undergo syst

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Among patients with liver cancer, biliary tract cancer, and pancreatic cancer aged 19 years or older who are undergoing systemic chemotherapy, patients who voluntarily agree in writing to participate in this study using VR therapy are targeted.

Exclusion criteria

Exclusion criteria: Patients with cognitive decline, vision (including color perception) or hearing loss, or facial defect, damage or deformity, brain damage, or epilepsy that are not suitable for applying VR are excluded.

Design outcomes

Primary

Measure	Time frame
The MME (Mean total milligrams of morphine equivalent) of opioids administered during the observation period (12 weeks) are measured.	—

Secondary

Measure	Time frame
patient-reported outcomes with pain, anxiety, and quality of life	—

Countries

Korea, Republic of

Contacts

Public ContactMoonho Kim

University of Ulsan

muno0802@hanmail.net+82-33-6104-4265

Outcome results